Advanced Certificate in Biotech Valuation & Portfolio Strategy
-- ViewingNowThe Advanced Certificate in Biotech Valuation & Portfolio Strategy course is a comprehensive program designed to equip learners with crucial skills in biotechnology valuation and investment strategy.
3,175+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Advanced Biotech Valuation Methods: This unit will cover the various methodologies used to value biotech companies, including discounted cash flow, comparables, and precedent transactions.
⢠Financial Analysis for Biotech Firms: Students will learn how to analyze financial statements of biotech firms to assess their financial health and growth potential.
⢠Intellectual Property & Biotech Valuation: This unit will cover the role of intellectual property, such as patents, in biotech valuation, and how to assess the value of a company's IP portfolio.
⢠Risk Analysis in Biotech Valuation: Students will learn how to identify and quantify risks associated with biotech companies and how to incorporate them into valuation models.
⢠Biotech Portfolio Management: This unit will cover best practices for building and managing a portfolio of biotech investments, including diversification, position sizing, and rebalancing.
⢠Emerging Trends in Biotech: Students will learn about emerging trends in the biotech industry, such as personalized medicine, gene editing, and synthetic biology, and how they may impact valuation and investment strategies.
⢠Mergers, Acquisitions & Partnerships in Biotech: This unit will cover the role of M&A and partnerships in the biotech industry, including how they are structured, valued, and executed.
⢠Regulatory & Policy Considerations in Biotech Valuation: Students will learn about the regulatory and policy environment for biotech companies, including the role of the FDA, reimbursement policies, and intellectual property laws.
⢠Case Studies in Biotech Valuation & Portfolio Strategy: This unit will provide real-world examples of successful biotech valuation and portfolio strategies, as well as case studies of companies that have struggled or failed.
⢠Ethical Considerations in Biotech Valuation & Investment: This unit will cover ethical considerations for biotech valuation and investment, including issues related to patient safety, access to healthcare, and the role of investors in shaping the industry.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë